Dongfang Liu

19PUBLICATIONS
62CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 06, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

|Jun 03, 2024
The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.

Puneeth Guruprasad, Alberto Carturan, Yunlin Zhang

|May 20, 2024
S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.

Minh Tuyet Ma, Qingkui Jiang, Chih-Hsiung Chen

|May 01, 2024
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager.

Zhuo Yang, Yingqin Hou, Geramie Grande

|Apr 27, 2024
Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.

Kevin C Lahey, Christopher Varsanyi, Ziren Wang

Pageof 4